{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:40:33Z","timestamp":1793248833070,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Funds for the Innovation of Science and Technology, Fujian province","award":["2021Y9221"],"award-info":[{"award-number":["2021Y9221"]}]},{"name":"First Batch of High-level Talent Training Program of Fujian Cancer Hospital","award":["2022YNG18"],"award-info":[{"award-number":["2022YNG18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07695-0","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:47:13Z","timestamp":1770461233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["LDHC4 promotes ovarian cancer progression through H4K12 lactylation to regulate PGK1 expression and modulate glycolysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yingying","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5543-4952","authenticated-orcid":false,"given":"Zhaolei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"7695_CR1","doi-asserted-by":"crossref","unstructured":"Smolarz B, Biernacka K, \u0141ukasiewicz H, Samulak D, Piekarska E, Romanowicz H, Makowska M. Ovarian cancer-epidemiology, classification, pathogenesis, treatment, and estrogen receptors\u2019 molecular backgrounds. Int J Mol Sci 2025:26.","DOI":"10.3390\/ijms26104611"},{"key":"7695_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-025-01660-y","volume":"18","author":"T Li","year":"2025","unstructured":"Li T, Zhang H, Lian M, He Q, Lv M, Zhai L, Zhou J, Wu K, Yi M. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. J Hematol Oncol. 2025;18:5.","journal-title":"J Hematol Oncol"},{"key":"7695_CR3","doi-asserted-by":"publisher","first-page":"104001","DOI":"10.1016\/j.ebiom.2022.104001","volume":"79","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Bi M, Guo H, Li M. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis. EBioMedicine. 2022;79:104001.","journal-title":"EBioMedicine"},{"key":"7695_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/jwh.2023.1160","volume":"33","author":"RJ Bergin","year":"2024","unstructured":"Bergin RJ, O\u2019Sullivan D, Dixon-Suen S, Emery JD, English DR, Milne RL, White VM. Time to diagnosis and treatment for ovarian cancer and associations with outcomes: A systematic review. J Womens Health (Larchmt). 2024;33:1185\u201397.","journal-title":"J Womens Health (Larchmt)"},{"key":"7695_CR5","doi-asserted-by":"publisher","first-page":"119705","DOI":"10.1016\/j.bbamcr.2024.119705","volume":"1871","author":"M Kielbik","year":"2024","unstructured":"Kielbik M, Szulc-Kielbik I, Klink M. Snail transcription factors - Characteristics, regulation and molecular targets relevant in vital cellular activities of ovarian cancer cells. Biochim Biophys Acta Mol Cell Res. 2024;1871:119705.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"7695_CR6","first-page":"166","volume":"30","author":"P Ramalingam","year":"2016","unstructured":"Ramalingam P. Morphologic, Immunophenotypic, and molecular features of epithelial ovarian cancer. Oncol (Williston Park). 2016;30:166\u201376.","journal-title":"Oncol (Williston Park)"},{"key":"7695_CR7","doi-asserted-by":"publisher","first-page":"e1284","DOI":"10.1002\/iid3.1284","volume":"12","author":"L Lin","year":"2024","unstructured":"Lin L, Zou X, Nong W, Ge Y, Li F, Luo B, Zhang Q, Xie X. The potential value of cancer-testis antigens in ovarian cancer: prognostic markers and targets for immunotherapy. Immun Inflamm Dis. 2024;12:e1284.","journal-title":"Immun Inflamm Dis"},{"key":"7695_CR8","doi-asserted-by":"publisher","first-page":"936767","DOI":"10.3389\/fonc.2022.936767","volume":"12","author":"J Wu","year":"2022","unstructured":"Wu J, Chen Y, Lin Y, Lan F, Cui Z. Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer. Front Oncol. 2022;12:936767.","journal-title":"Front Oncol"},{"key":"7695_CR9","doi-asserted-by":"publisher","first-page":"1564731","DOI":"10.3389\/fimmu.2025.1564731","volume":"16","author":"R Zhong","year":"2025","unstructured":"Zhong R, Guo X, Wu C, Guo Y, Kang Y, You J, Chen F, Chen Q, Chen L. Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from LDHC in lung adenocarcinoma. Front Immunol. 2025;16:1564731.","journal-title":"Front Immunol"},{"key":"7695_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12964-025-02139-6","volume":"23","author":"A Naik","year":"2025","unstructured":"Naik A, Thomas R, Al-Khalifa A, Qasem H, Decock J. Immunomodulatory effects of tumor lactate dehydrogenase C (LDHC) in breast cancer. Cell Commun Signal. 2025;23:145.","journal-title":"Cell Commun Signal"},{"key":"7695_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00262-020-02480-4","volume":"69","author":"R Thomas","year":"2020","unstructured":"Thomas R, Shaath H, Naik A, Toor SM, Elkord E, Decock J. Identification of two HLA-A*0201 Immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy. Cancer Immunol Immunother. 2020;69:449\u201363.","journal-title":"Cancer Immunol Immunother"},{"key":"7695_CR12","doi-asserted-by":"publisher","first-page":"112414","DOI":"10.1016\/j.yexcr.2020.112414","volume":"398","author":"L Chen","year":"2021","unstructured":"Chen L, Wu Q, Xu X, Yang C, You J, Chen F, Zeng Y. Cancer\/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K\/Akt\/GSK-3\u03b2-signaling pathway and the in lung adenocarcinoma. Exp Cell Res. 2021;398:112414.","journal-title":"Exp Cell Res"},{"key":"7695_CR13","doi-asserted-by":"publisher","first-page":"101042831769596","DOI":"10.1177\/1010428317695968","volume":"39","author":"Y Hua","year":"2017","unstructured":"Hua Y, Liang C, Zhu J, Miao C, Yu Y, Xu A, Zhang J, Li P, Li S, Bao M, et al. Expression of lactate dehydrogenase C correlates with poor prognosis in renal cell carcinoma. Tumour Biol. 2017;39:1010428317695968.","journal-title":"Tumour Biol"},{"key":"7695_CR14","doi-asserted-by":"publisher","first-page":"19455","DOI":"10.18632\/aging.103879","volume":"12","author":"Z Cui","year":"2020","unstructured":"Cui Z, Li Y, Gao Y, Kong L, Lin Y, Chen Y. Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction. Aging. 2020;12:19455\u201367.","journal-title":"Aging"},{"key":"7695_CR15","doi-asserted-by":"publisher","first-page":"912624","DOI":"10.3389\/fonc.2022.912624","volume":"12","author":"W Peng","year":"2022","unstructured":"Peng W, Chen J, Xiao Y, Su G, Chen Y, Cui Z. Cancer-Testis antigen LDH-C4 in Tissue, Serum, and Serum-Derived exosomes serves as a promising biomarker in lung adenocarcinoma. Front Oncol. 2022;12:912624.","journal-title":"Front Oncol"},{"key":"7695_CR16","doi-asserted-by":"crossref","unstructured":"Cui Z, Zheng C, Lin Y, Xiao Z, Li Y, Peng W, He S, Li A, Wu X, Chen Y, Sun Y. Lactate dehydrogenase C4 accelerates triple-negative breast cancer progression by promoting acetyl-CoA acyltransferase 2 lactylation to increase free fatty acid accumulation. Adv Sci (Weinh) 2025:e11849.","DOI":"10.1002\/advs.202511849"},{"key":"7695_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cca.2019.11.032","volume":"503","author":"Z Cui","year":"2020","unstructured":"Cui Z, Chen Y, Hu M, Lin Y, Zhang S, Kong L, Chen Y. Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer. Clin Chim Acta. 2020;503:203\u20139.","journal-title":"Clin Chim Acta"},{"key":"7695_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2164\/jandrol.109.008367","volume":"31","author":"E Goldberg","year":"2010","unstructured":"Goldberg E, Eddy EM, Duan C, Odet F. LDHC: the ultimate testis-specific gene. J Androl. 2010;31:86\u201394.","journal-title":"J Androl"},{"key":"7695_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1095\/biolreprod.108.068353","volume":"79","author":"F Odet","year":"2008","unstructured":"Odet F, Duan C, Willis WD, Goulding EH, Kung A, Eddy EM, Goldberg E. Expression of the gene for mouse lactate dehydrogenase C (Ldhc) is required for male fertility. Biol Reprod. 2008;79:26\u201334.","journal-title":"Biol Reprod"},{"key":"7695_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.","journal-title":"Mol Cancer"},{"key":"7695_CR21","doi-asserted-by":"publisher","first-page":"115064","DOI":"10.1016\/j.celrep.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, Xia Z, Xia W, Jiang P. Metabolic reprogramming, sensing, and cancer therapy. Cell Rep. 2024;43:115064.","journal-title":"Cell Rep"},{"key":"7695_CR22","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang K, Wang X, Song C, He Z, Wang R, Xu Y, Jiang G, Wan Y, Mei J, Mao W. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023;13:1774\u2013808.","journal-title":"Theranostics"},{"key":"7695_CR23","first-page":"9950","volume":"13","author":"C Nantasupha","year":"2021","unstructured":"Nantasupha C, Thonusin C, Charoenkwan K, Chattipakorn S, Chattipakorn N. Metabolic reprogramming in epithelial ovarian cancer. Am J Transl Res. 2021;13:9950\u201373.","journal-title":"Am J Transl Res"},{"key":"7695_CR24","doi-asserted-by":"publisher","first-page":"108413","DOI":"10.1016\/j.pharmthera.2023.108413","volume":"245","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang Y, Zhao G, Orsulic S, Matei D. Metabolic dependencies and targets in ovarian cancer. Pharmacol Ther. 2023;245:108413.","journal-title":"Pharmacol Ther"},{"key":"7695_CR25","doi-asserted-by":"crossref","unstructured":"Kumar S, Mittal S, Gupta P, Singh M, Chaluvally-Raghavan P, Pradeep S. Metabolic reprogramming in tumor-associated macrophages in the ovarian tumor microenvironment. Cancers (Basel) 2022:14.","DOI":"10.3390\/cancers14215224"},{"key":"7695_CR26","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/erm.2022.42","volume":"25","author":"X Lv","year":"2023","unstructured":"Lv X, Lv Y, Dai X. Lactate, histone lactylation and cancer hallmarks. Expert Rev Mol Med. 2023;25:e7.","journal-title":"Expert Rev Mol Med"},{"key":"7695_CR27","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","volume":"42","author":"H Li","year":"2024","unstructured":"Li H, Sun L, Gao P, Hu H. Lactylation in cancer: current Understanding and challenges. Cancer Cell. 2024;42:1803\u20137.","journal-title":"Cancer Cell"},{"key":"7695_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, Yao Y, Xu S, Ge S, Jia R. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38.","journal-title":"Signal Transduct Target Ther"},{"key":"7695_CR29","doi-asserted-by":"publisher","first-page":"e3002666","DOI":"10.1371\/journal.pbio.3002666","volume":"22","author":"X Hou","year":"2024","unstructured":"Hou X, Ouyang J, Tang L, Wu P, Deng X, Yan Q, Shi L, Fan S, Fan C, Guo C, et al. KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation. PLoS Biol. 2024;22:e3002666.","journal-title":"PLoS Biol"},{"key":"7695_CR30","doi-asserted-by":"publisher","first-page":"216285","DOI":"10.1016\/j.canlet.2023.216285","volume":"567","author":"M Chen","year":"2023","unstructured":"Chen M, Cen K, Song Y, Zhang X, Liou YC, Liu P, Huang J, Ruan J, He J, Ye W, et al. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma. Cancer Lett. 2023;567:216285.","journal-title":"Cancer Lett"},{"key":"7695_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2022.05.028","volume":"615","author":"F Nian","year":"2022","unstructured":"Nian F, Qian Y, Xu F, Yang M, Wang H, Zhang Z. LDHA promotes osteoblast differentiation through histone lactylation. Biochem Biophys Res Commun. 2022;615:31\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"7695_CR32","doi-asserted-by":"publisher","first-page":"1328679","DOI":"10.3389\/fendo.2024.1328679","volume":"15","author":"Z Cui","year":"2024","unstructured":"Cui Z, Li Y, Lin Y, Zheng C, Luo L, Hu D, Chen Y, Xiao Z, Sun Y. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer. Front Endocrinol (Lausanne). 2024;15:1328679.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7695_CR33","first-page":"100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Camb). 2024;5:100625.","journal-title":"Innov (Camb)"},{"key":"7695_CR34","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00404-022-06433-3","volume":"306","author":"D Hu","year":"2022","unstructured":"Hu D, Cui Z, Peng W, Wang X, Chen Y, Wu X. Apelin is associated with clinicopathological parameters and prognosis in breast cancer patients. Arch Gynecol Obstet. 2022;306:1185\u201395.","journal-title":"Arch Gynecol Obstet"},{"key":"7695_CR35","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur HS, Wu SJ, Codomo CA, Pledger ES, Bryson TD, Henikoff JG, Ahmad K, Henikoff S. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat Commun. 2019;10:1930.","journal-title":"Nat Commun"},{"key":"7695_CR36","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-018-0622-0","volume":"562","author":"MJ Bollong","year":"2018","unstructured":"Bollong MJ, Lee G, Coukos JS, Yun H, Zambaldo C, Chang JW, Chin EN, Ahmad I, Chatterjee AK, Lairson LL, et al. A metabolite-derived protein modification integrates Glycolysis with KEAP1-NRF2 signalling. Nature. 2018;562:600\u20134.","journal-title":"Nature"},{"key":"7695_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.cancergen.2011.09.004","volume":"204","author":"JI Weberpals","year":"2011","unstructured":"Weberpals JI, Koti M, Squire JA. Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer. Cancer Genet. 2011;204:525\u201335.","journal-title":"Cancer Genet"},{"key":"7695_CR38","doi-asserted-by":"publisher","first-page":"682461","DOI":"10.3389\/fonc.2021.682461","volume":"11","author":"R Gou","year":"2021","unstructured":"Gou R, Hu Y, Liu O, Dong H, Gao L, Wang S, Zheng M, Li X, Lin B. PGK1 is a key target for Anti-Glycolytic therapy of ovarian cancer: based on the comprehensive analysis of Glycolysis-Related genes. Front Oncol. 2021;11:682461.","journal-title":"Front Oncol"},{"key":"7695_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie H, Ju H, Fan J, Shi X, Cheng Y, Cang X, Zheng Z, Duan X, Yi W. O-GlcNAcylation of PGK1 coordinates Glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020;11:36.","journal-title":"Nat Commun"},{"key":"7695_CR40","doi-asserted-by":"publisher","first-page":"111468","DOI":"10.1016\/j.cellsig.2024.111468","volume":"124","author":"J Li","year":"2024","unstructured":"Li J, Chen Z, Jin M, Gu X, Wang Y, Huang G, Zhao W, Lu C. Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. Cell Signal. 2024;124:111468.","journal-title":"Cell Signal"},{"key":"7695_CR41","doi-asserted-by":"crossref","unstructured":"Tang Y, Li Y, Yang X, Lu T, Wang X, Li Z, Liu J, Wang J. Intestinal metabolite TMAO promotes CKD progression by stimulating macrophage M2 polarization through histone H4 lysine 12 lactylation. Cell Death Differ 2025.","DOI":"10.1038\/s41418-025-01554-z"},{"key":"7695_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-025-07498-z","volume":"16","author":"J Deng","year":"2025","unstructured":"Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, Mu L, Luo X, Qin J. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16:193.","journal-title":"Cell Death Dis"},{"key":"7695_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s42255-022-00575-z","volume":"4","author":"Q Liu","year":"2022","unstructured":"Liu Q, Zhu F, Liu X, Lu Y, Yao K, Tian N, Tong L, Figge DA, Wang X, Han Y, et al. Non-oxidative Pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics. Nat Metab. 2022;4:559\u201374.","journal-title":"Nat Metab"},{"key":"7695_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, Jia R. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22:85.","journal-title":"Genome Biol"},{"key":"7695_CR45","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1038\/s41467-024-51232-w","volume":"15","author":"Z Guo","year":"2024","unstructured":"Guo Z, Zhang Y, Wang H, Liao L, Ma L, Zhao Y, Yang R, Li X, Niu J, Chu Q, et al. Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating Glycolysis and the TCA cycle. Nat Commun. 2024;15:6915.","journal-title":"Nat Commun"},{"key":"7695_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molcel.2018.06.023","volume":"71","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Yu G, Chu H, Wang X, Xiong L, Cai G, Liu R, Gao H, Tao B, Li W, et al. Macrophage-Associated PGK1 phosphorylation promotes aerobic Glycolysis and tumorigenesis. Mol Cell. 2018;71:201\u2013e215207.","journal-title":"Mol Cell"},{"key":"7695_CR47","first-page":"2280","volume":"9","author":"Y He","year":"2019","unstructured":"He Y, Luo Y, Zhang D, Wang X, Zhang P, Li H, Ejaz S, Liang S. PGK1-mediated cancer progression and drug resistance. Am J Cancer Res. 2019;9:2280\u2013302.","journal-title":"Am J Cancer Res"},{"key":"7695_CR48","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41418-024-01436-w","volume":"32","author":"H Hong","year":"2025","unstructured":"Hong H, Han H, Wang L, Cao W, Hu M, Li J, Wang J, Yang Y, Xu X, Li G, et al. ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway. Cell Death Differ. 2025;32:613\u201331.","journal-title":"Cell Death Differ"},{"key":"7695_CR49","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.drup.2025.101248","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wang H, Cui Z, Yu T, Song Y, Gao H, Tang R, Wang X, Li B, Li W, Wang Z. Lactylation in cancer progression and drug resistance. Drug Resist Updat. 2025;81:101248.","journal-title":"Drug Resist Updat"},{"key":"7695_CR50","doi-asserted-by":"publisher","first-page":"217835","DOI":"10.1016\/j.canlet.2025.217835","volume":"627","author":"W Zhu","year":"2025","unstructured":"Zhu W, Fan C, Hou Y, Zhang Y. Lactylation in tumor microenvironment and immunotherapy resistance: new mechanisms and challenges. Cancer Lett. 2025;627:217835.","journal-title":"Cancer Lett"},{"key":"7695_CR51","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40265-017-0739-8","volume":"77","author":"ZT Al-Salama","year":"2017","unstructured":"Al-Salama ZT, Deeks ED. Elbasvir\/Grazoprevir: A review in chronic HCV genotypes 1 and 4. Drugs. 2017;77:911\u201321.","journal-title":"Drugs"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07695-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:02:46Z","timestamp":1773230566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7695"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07695-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Laboratory Animal Welfare and Ethics Committee of Cyagen Biosciences (Suzhou) Co., Ltd (Ethics Approval No: TACU25-SY055), and all animals received humane care throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"351"}}